Related Experiment Video

Updated: Jul 7, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Methamphetamine enhances Hepatitis C virus replication in human hepatocytes

L Ye1, J S Peng, X Wang

  • 1Division of Allergy & Immunology, Joseph Stokes, Jr. Research Institute at The Children's Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

Journal of Viral Hepatitis
|March 1, 2008
PubMed

Insights

Methamphetamine use impairs innate immunity by inhibiting interferon alpha, which increases hepatitis C virus (HCV) replication. This drug may worsen HCV disease progression by compromising the body's natural defenses.

Area of Science:

  • Hepatology
  • Immunology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is a global health concern.
  • Methamphetamine abuse is linked to increased risk of HIV/HCV infection.
  • The interaction between methamphetamine and HCV, particularly concerning innate immunity, remains poorly understood.

Purpose of the Study:

  • To investigate the effect of methamphetamine on innate immunity in human hepatocytes.
  • To determine if methamphetamine facilitates HCV replication.
  • To elucidate the molecular mechanisms underlying methamphetamine's impact on antiviral pathways.

Main Methods:

  • In vitro study using human hepatocytes.
  • Assessed intracellular interferon alpha expression.
  • Measured HCV replication levels.
  • Investigated the expression of key immune modulators like STAT1 and IRF-5.

Main Results:

  • Methamphetamine significantly inhibited intracellular interferon alpha expression in hepatocytes.
  • This inhibition correlated with increased HCV replication.
  • Methamphetamine compromised the antiviral efficacy of exogenous interferon alpha.
  • Down-regulation of Signal Transducer and Activator of Transcription 1 (STAT1) and Interferon Regulatory Factor-5 (IRF-5) was observed.

Conclusions:

  • Methamphetamine impairs interferon alpha-mediated innate immunity against HCV.
  • The drug may act as a cofactor in HCV immunopathogenesis.
  • Findings highlight potential therapeutic targets for managing HCV in methamphetamine users.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...